Eloxatin

Active Ingredient(s): Oxaliplatin
FDA Approved: * August 9, 2002
Pharm Company: * SANOFI AVENTIS US
Category: Cancer

Oxaliplatin, sold under the brand name Eloxatin, is a cancer medication (platinum-based antineoplastic class) used to treat colorectal cancer.[2] Often it is used together with fluorouracil and folinic acid (leucovorin) in advanced cancer.[2] It is given by injection into a vein.[2] Common side effects include numbness, feeling tired, nausea, diarrhea, and low blood cell counts.[2][3] Other serious side effects in... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Eloxatin 5 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0024-0590
Labeler:
Sanofi-aventis U.S. LLC
Eloxatin 5 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0024-0591
Labeler:
Sanofi-aventis U.S. LLC
Eloxatin 5 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 12516-0592
Labeler:
Aventis Pharma Ltd.